Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Longerich

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
Oncogene|February 15, 2020
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesisSarah Luiken, Angelika Fraas, Matthias Bieg, et al.
Cancers|September 24, 2020
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer SubtypesMark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, et al.
The Journal of Clinical Investigation|March 3, 2011
The liver-specific microRNA miR-122 controls systemic iron homeostasis in miceMirco Castoldi, Maja Vujic Spasic, Sandro Altamura, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 26, 2013
Irreversible electroporation of the pig kidney with involvement of the renal pelvis: technical aspects, clinical outcome, and three-dimensional CT rendering for assessment of the treatment zoneChristof M Sommer, Stefan Fritz, Miguel F Wachter, et al.
Gut|January 27, 2023
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockadeClaire Conche, Fabian Finkelmeier, Marina Pešić, et al.
Pediatric Pulmonology|August 25, 2020
Rescue of respiratory failure in pulmonary alveolar proteinosis due to pathogenic MARS1 variantsDominic Lenz, Mirjam Stahl, Elias Seidl, et al.
Nature Medicine|May 24, 2016
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancerDaniel Dauch, Ramona Rudalska, Giacomo Cossa, et al.
Molecular Cell|October 30, 2012
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genesStephan Singer, Ruiying Zhao, Anthony M Barsotti, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Gut|September 30, 2024
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinomaHenrike Salié, Lara Wischer, Antonio D'Alessio, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
Oncogene|February 15, 2020
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesisSarah Luiken, Angelika Fraas, Matthias Bieg, et al.
Cancers|September 24, 2020
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer SubtypesMark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, et al.
The Journal of Clinical Investigation|March 3, 2011
The liver-specific microRNA miR-122 controls systemic iron homeostasis in miceMirco Castoldi, Maja Vujic Spasic, Sandro Altamura, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 26, 2013
Irreversible electroporation of the pig kidney with involvement of the renal pelvis: technical aspects, clinical outcome, and three-dimensional CT rendering for assessment of the treatment zoneChristof M Sommer, Stefan Fritz, Miguel F Wachter, et al.
Gut|January 27, 2023
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockadeClaire Conche, Fabian Finkelmeier, Marina Pešić, et al.
Pediatric Pulmonology|August 25, 2020
Rescue of respiratory failure in pulmonary alveolar proteinosis due to pathogenic MARS1 variantsDominic Lenz, Mirjam Stahl, Elias Seidl, et al.
Nature Medicine|May 24, 2016
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancerDaniel Dauch, Ramona Rudalska, Giacomo Cossa, et al.
Molecular Cell|October 30, 2012
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genesStephan Singer, Ruiying Zhao, Anthony M Barsotti, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Gut|September 30, 2024
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinomaHenrike Salié, Lara Wischer, Antonio D'Alessio, et al.
Pageof 23